Congress Aims to Expand Access to Clinical Trials
New legislation could make it easier for people to participate in clinical trials regardless of their economic situation.
Medicare Patients Could Gain Access to Critical Diagnostic Test
Nearly 1.7 million Americans learned they had cancer in 2017. Most of these patients began traditional treatments like chemotherapy, radiation and surgery. Yet for many, a groundbreaking new immuno-oncology therapy could have been a better alternative.
Perspective: My Clinical Trials Awareness Journey
The need for robust clinical trials participation is critical to women and men across this country, whether they know it or not.
Drug Approval Signals New Era in Cancer Care
Is precision medicine gaining traction in the field of oncology? The Food and Drug Administration’s recent approval of the cancer drug pembrolizumab offers a hint.
Precision Medicine Initiative Raises Hopes for Personalized Medicine
The first anniversary of the White House’s Precision Medicine Initiative gave participants time to reflect on the year’s progress – and contemplate the challenges ahead.
